» Articles » PMID: 27584793

HSV-1-induced Activation of NF-κB Protects U937 Monocytic Cells Against Both Virus Replication and Apoptosis

Overview
Journal Cell Death Dis
Date 2016 Sep 2
PMID 27584793
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor nuclear factor-kappa B (NF-κB) is a crucial player of the antiviral innate response. Intriguingly, however, NF-κB activation is assumed to favour herpes simplex virus (HSV) infection rather than restrict it. Apoptosis, a form of innate response to viruses, is completely inhibited by HSV in fully permissive cells, but not in cells incapable to fully sustain HSV replication, such as immunocompetent cells. To resolve the intricate interplay among NF-κB signalling, apoptosis and permissiveness to HSV-1 in monocytic cells, we utilized U937 monocytic cells in which NF-κB activation was inhibited by expressing a dominant-negative IκBα. Surprisingly, viral production was increased in monocytic cells in which NF-κB was inhibited. Moreover, inhibition of NF-κB led to increased apoptosis following HSV-1 infection, associated with lysosomal membrane permeabilization. High expression of late viral proteins and induction of apoptosis occurred in distinct cells. Transcriptional analysis of known innate response genes by real-time quantitative reverse transcription-PCR excluded a contribution of the assayed genes to the observed phenomena. Thus, in monocytic cells NF-κB activation simultaneously serves as an innate process to restrict viral replication as well as a mechanism to limit the damage of an excessive apoptotic response to HSV-1 infection. This finding may clarify mechanisms controlling HSV-1 infection in monocytic cells.

Citing Articles

Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB.

Hou P, Zhu H, Chu F, Gao Y, Sun X, Zhang F Nat Commun. 2025; 16(1):496.

PMID: 39779683 PMC: 11711403. DOI: 10.1038/s41467-024-54882-y.


DNA-PK and ATM drive phosphorylation signatures that antagonistically regulate cytokine responses to herpesvirus infection or DNA damage.

Justice J, Reed T, Phelan B, Greco T, Hutton J, Cristea I Cell Syst. 2024; 15(4):339-361.e8.

PMID: 38593799 PMC: 11098675. DOI: 10.1016/j.cels.2024.03.003.


Human cytomegalovirus UL36 inhibits IRF3-dependent immune signaling to counterbalance its immunoenhancement as apoptotic inhibitor.

Ren Y, Wang A, Zhang B, Ji W, Zhu X, Lou J Sci Adv. 2023; 9(40):eadi6586.

PMID: 37792941 PMC: 10550242. DOI: 10.1126/sciadv.adi6586.


Antioxidant Activity of a Sicilian Almond Skin Extract Using In Vitro and In Vivo Models.

Arangia A, Ragno A, Cordaro M, DAmico R, Siracusa R, Fusco R Int J Mol Sci. 2023; 24(15).

PMID: 37569490 PMC: 10418603. DOI: 10.3390/ijms241512115.


Immunopathogenesis of viral infections in neurological autoimmune disease.

Habibi M, Nezhad Shamohammadi F, Rajaei T, Namdari H, Pashaei M, Farajifard H BMC Neurol. 2023; 23(1):201.

PMID: 37221459 PMC: 10203689. DOI: 10.1186/s12883-023-03239-x.


References
1.
Hiscott J . Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 2007; 18(5-6):483-90. DOI: 10.1016/j.cytogfr.2007.06.002. View

2.
Kim J, Lee S, Kim S, Kim J, Kim H, Lee H . HSV-1 ICP27 suppresses NF-kappaB activity by stabilizing IkappaBalpha. FEBS Lett. 2008; 582(16):2371-6. DOI: 10.1016/j.febslet.2008.05.044. View

3.
van Lint A, Murawski M, Goodbody R, Severa M, Fitzgerald K, Finberg R . Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J Virol. 2010; 84(20):10802-11. PMC: 2950559. DOI: 10.1128/JVI.00063-10. View

4.
Vanden Oever M, Han J . Caspase 9 is essential for herpes simplex virus type 2-induced apoptosis in T cells. J Virol. 2010; 84(6):3116-20. PMC: 2826057. DOI: 10.1128/JVI.01726-09. View

5.
Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe D . Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc Natl Acad Sci U S A. 2008; 105(32):11335-9. PMC: 2516262. DOI: 10.1073/pnas.0801617105. View